Although we cannot rule out that the Aβ pathology might have evolved toward an AD phenotype had the Aβ positive iCJD patients lived longer and not died of CJD this possibility is unlikely since no significant differences were found between the UK GH-iCJD and hGH recipients free of CJD. The gene discussed is GH1; the disease is Creutzfeldt Jacob disease.